Related references
Note: Only part of the references are listed.The effects of losartan on signal-averaged P wave in patients with atrial fibrillation
Masahiro Nomura et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program
Lars G. Olsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation
A Boldt et al.
BASIC RESEARCH IN CARDIOLOGY (2006)
Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes
DP Zankov et al.
CIRCULATION (2006)
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence
JR Ehrlich et al.
EUROPEAN HEART JOURNAL (2006)
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients
R Fogari et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: A randomized clinical study
T Celik et al.
CLINICAL CARDIOLOGY (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol -: The Losartan Intervention For End point reduction in hypertension (LIFE) study
K Wachtell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:: Results from the Valsartan Heart Failure Trial (Val-HeFT)
AP Maggioni et al.
AMERICAN HEART JOURNAL (2005)
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis -: Results of a randomized trial
MM Ciulla et al.
CIRCULATION (2004)
Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
A Boldt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
K Kumagai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction - Insight from the studies of left ventricular dysfunction (SOLVD) trials
E Vermes et al.
CIRCULATION (2003)
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation - Results of a prospective and controlled study
KC Ueng et al.
EUROPEAN HEART JOURNAL (2003)
A population-based study of mortality among patients with atrial fibrillation or flutter
H Vidaillet et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study
AH Madrid et al.
CIRCULATION (2002)
Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling
K Shinagawa et al.
CARDIOVASCULAR RESEARCH (2002)
Electrical, contractile and structural remodeling during atrial fibrillation
M Allessie et al.
CARDIOVASCULAR RESEARCH (2002)
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
DS Li et al.
CIRCULATION (2001)
P-wave dispersion: A novel predictor of paroxysmal atrial fibrillation
PE Dilaveris et al.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2001)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
H Nakashima et al.
CIRCULATION (2000)
Losartan and its metabolite E3174 modify cardiac delayed rectifier K+ currents
R Caballero et al.
CIRCULATION (2000)
Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
A Goette et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)